Cancel

AMD in 2017: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

This continuing medical education (CME) activity captures content from a roundtable discussion held in September 2016. Despite the development of treatment options for common retinal diseases and the published results of many pivotal studies for these diseases, clinical experience and real-world dosing methods continue to vary and treatment remains a challenge. This roundtable addresses some of these challenges and examines outcomes of the clinical trials versus what retinal specialists encou...
Evolve Medical Education LLC

Inflamed and Untamed: Managing the Progression of Diabetic Eye Disease

Diabetic retinopathy (DR) is a major cause of blindness, with an estimated 4.2 million people over the age of 40 affected by this condition within the United States. Loss of vision is most frequently due to diabetic macular edema (DME), a consequence of DR, but it can also be a direct result of DR. Inflammation plays an important role in the pathogenesis of DME, and recent advances in the understanding of the underlying pathophysiology of the disease have led to the development of therapies fo...
Slack Inc.

Treating Advanced Dry Age-related Macular Degeneration and Geographic Atrophy: Here and Now

Age-related macular degeneration (AMD) is a deterioration or breakdown of the eye's macula. At present, pharmacotherapy is available only for late neovascular AMD. The prospect of effective therapies in the near future, together with an increasing incidence of AMD in an aging population, has led to increased interest in early, accurate diagnosis and classification of AMD, as well as medications to effectively treat it. This educational program will address imaging techniques and technology, ev...
Slack Inc.

From Trials to Treatments Real World Applications in Medical and Surgical Retina

Retinal disorders, including age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) can result in vision loss if not treated early and—in some disorders—continuously. Significant challenges lie ahead in addressing these patients’ needs, as healthcare providers are being tasked with treating increasing numbers of patients. Prevent Blindness America has found the total healthcare costs of vision problems in the U.S. in people older than 40 ye...
Evolve Medical Education LLC

Early Treatment of Diabetic Retinopathy and Diabetic Macular Edema: Optimal Use of Anti-VEGF Therapy for Vision Preservation and Restoration

Diabetic retinopathy (DR) and diabetic macular edema (DME) are 2 of the most common causes of blindness among working-age people throughout the world. Effective management depends heavily on prompt treatment. Many of these patients remain untreated, however; as a result, they often suffer irrevocable vision loss that might have been prevented. Retina specialists and comprehensive ophthalmologists, who play a crucial role in the treatment of DR and DME, will require education to overcome defici...
Slack Inc.

Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing Part 2 of 2

This continuing medical education (CME) activity captures content from roundtable discussion held in June of 2017. Age-related macular degeneration (AMD) is a chronic, progressive disease. It is a leading cause of blindness in developed countries,1-4 with an overall global prevalence of 8.69%. AMD is most prevalent in patients older than 60 years, with incidence rates expected to increase as the population ages—approximately 228 million people will be diagnosed with AMD in 2040.5 There is n...
Evolve Medical Education LLC

Avoiding the Blind Spot: Facts, Figures, and Findings about Myopic Choroidal Neovascularization

Myopic choroidal neovascularization (mCNV) is a rare complication of myopia with a high-risk of long-term vision loss if not differentially diagnosed early and treated promptly. Furthermore, approximately 35% of patients diagnosed with mCNV in one eye will develop mCNV in the other eye within 10 years. Misdiagnosis is common because mCNV shares similar clinical characteristics to age-related macular degeneration resulting in delayed and inappropriate management. Treatment options for mCNV with...
Slack Inc.

Geographic Atrophy Secondary to Age-related Macular Degeneration: Classification and Treatment

Geographic atrophy (GA), an advanced form of age-related macular degradation (AMD) affects approximately 5 million individuals worldwide. Advances in predictive and diagnostic techniques provide the opportunity for an earlier diagnosis of AMD yet currently, there are no approved therapies for the treatment of GA. In this live activity, held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium, experts in the field provide review and guidance for the classification of early to ...
Slack Inc.

Integrated Care for the Diabetic Patient How to Diagnose and Manage the At Risk Patient Part 1

After successfully completing this activity, optometrists will have improved their ability to: Determine who is a high-risk patient for the onset of diabetic eye disease Discuss the importance of conducting yearly dilated exams on diabetic patients Develop plans to initiate comanagement of the diabetic patient with both ophthalmologists and primary care physicians/endocrinologists Implement strategies to educate patients on the ocular manifestations of diabetes
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient: How to Diagnose and Manage the At-Risk Patient Webinar Part 3

It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious. The target audience for this CE Activity is Optometrists. Learning Objectives After successfully compl...
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient How to Diagnose and Manage the At Risk Patient Part 2 Supplement

This continuing education (CE) activity captures content from a roundtable discussion held in September 2016. It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye examinations, and discussing the potential treatments should vision loss becom...
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient: How to Diagnose and Manage the At-Risk Patient Webinar Part 2

It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious. The target audience for this CE Activity is Optometrists. Learning Objectives This educational activi...
Evolve Medical Education LLC

Osler Ophthalmology Online Review

After completing the Osler Ophthalmology Online Review, you will be able to: • Apply the basic principles of optics to refractory problems and how to correct them • Describe the anatomy and physiology of each separate unit of the eye • Discuss common ocular conditions and delineate how to correlate clinical and pathologic findings • Diagnose and manage common types of congenital and acquired disorders in children • Explain the process of cataract surgery and potential complicati...
Osler Institute

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.